Gt Biopharma Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.32

-0.03 (-7.96%)

As of May 16, 2:28 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +7,773.9% upside

Low Target $15.48

Average Target $24.85

High Target $31.61

Current Price $0.32

Current
$0.32

Target
$24.85

$15.48 $24.85 avg $31.61

Scenario Analysis

Bear Case

$15.48

4,804.9%

Low target

Base Case

$24.85

+7,773.9%

Avg target

Bull Case

$31.61

+9,915.8%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$3.85

-91.8% from high

52-Week Low

$0.26

+20.9% from low

Target vs 52W High

$24.85

+545.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%